207 related articles for article (PubMed ID: 28665480)
1. Simultaneous pancreas/kidney transplant recipients are predisposed to tissue-invasive cytomegalovirus disease and concomitant infectious complications.
Schachtner T; Zaks M; Otto NM; Kahl A; Reinke P
Transpl Infect Dis; 2017 Oct; 19(5):. PubMed ID: 28665480
[TBL] [Abstract][Full Text] [Related]
2. Simultaneous pancreas/kidney transplant recipients present with late-onset BK polyomavirus-associated nephropathy.
Schachtner T; Zaks M; Kahl A; Reinke P
Nephrol Dial Transplant; 2016 Jul; 31(7):1174-82. PubMed ID: 26758790
[TBL] [Abstract][Full Text] [Related]
3. Factors and outcomes in association with sepsis differ between simultaneous pancreas/kidney and single kidney transplant recipients.
Schachtner T; Zaks M; Otto NM; Kahl A; Reinke P
Transpl Infect Dis; 2018 Apr; 20(2):e12848. PubMed ID: 29359836
[TBL] [Abstract][Full Text] [Related]
4. CMV Viremia is associated with a decreased incidence of BKV reactivation after kidney and kidney-pancreas transplantation.
Elfadawy N; Flechner SM; Liu X; Schold J; Srinivas TR; Poggio E; Fatica R; Avery R; Mossad SB
Transplantation; 2013 Dec; 96(12):1097-103. PubMed ID: 24056621
[TBL] [Abstract][Full Text] [Related]
5. Kidney transplant recipients after nonrenal solid organ transplantation show low alloreactivity but an increased risk of infection.
Schachtner T; Stein M; Reinke P
Transpl Int; 2016 Dec; 29(12):1296-1306. PubMed ID: 27638250
[TBL] [Abstract][Full Text] [Related]
6. Choice of antibody immunotherapy influences cytomegalovirus viremia in simultaneous pancreas-kidney transplant recipients.
Huurman VA; Kalpoe JS; van de Linde P; Vaessen N; Ringers J; Kroes AC; Roep BO; De Fijter JW
Diabetes Care; 2006 Apr; 29(4):842-7. PubMed ID: 16567825
[TBL] [Abstract][Full Text] [Related]
7. Reassessing the impact of cytomegalovirus infection in kidney and kidney-pancreas transplantation.
Becker BN; Becker YT; Leverson GE; Simmons WD; Sollinger HW; Pirsch JD
Am J Kidney Dis; 2002 May; 39(5):1088-95. PubMed ID: 11979354
[TBL] [Abstract][Full Text] [Related]
8. ABO desensitization affects cellular immunity and infection control after renal transplantation.
Schachtner T; Stein M; Reinke P
Transpl Int; 2015 Oct; 28(10):1179-94. PubMed ID: 26033637
[TBL] [Abstract][Full Text] [Related]
9. Sepsis after renal transplantation: Clinical, immunological, and microbiological risk factors.
Schachtner T; Stein M; Reinke P
Transpl Infect Dis; 2017 Jun; 19(3):. PubMed ID: 28296035
[TBL] [Abstract][Full Text] [Related]
10. Polyomavirus and cytomegalovirus infections are risk factors for grafts loss in simultaneous pancreas and kidney transplant.
Aziz F; Jorgenson MR; Parajuli S; Zhong W; Hidalgo LG; Djamali A; Mandelbrot D; Odorico J; Sollinger H; Astor BC; Mohamed MA
Transpl Infect Dis; 2020 Jun; 22(3):e13272. PubMed ID: 32112710
[TBL] [Abstract][Full Text] [Related]
11. CMV-Specific T Cell Monitoring Offers Superior Risk Stratification of CMV-Seronegative Kidney Transplant Recipients of a CMV-Seropositive Donor.
Schachtner T; Stein M; Reinke P
Transplantation; 2017 Oct; 101(10):e315-e325. PubMed ID: 28594749
[TBL] [Abstract][Full Text] [Related]
12. Cytomegalovirus infection post-pancreas-kidney transplantation--results of antiviral prophylaxis in high-risk patients.
Fallatah SM; Marquez MA; Bazerbachi F; Schiff JR; Cattral MS; McGilvray ID; Norgate A; Selzner M; Rotstein C; Husain S
Clin Transplant; 2013; 27(4):503-9. PubMed ID: 23731387
[TBL] [Abstract][Full Text] [Related]
13. Pneumocystis jiroveci pneumonia in kidney and simultaneous pancreas kidney transplant recipients in the present era of routine post-transplant prophylaxis: risk factors and outcomes.
Garg N; Jorgenson M; Descourouez J; Saddler CM; Parajuli S; Astor BC; Djamali A; Mandelbrot D
BMC Nephrol; 2018 Nov; 19(1):332. PubMed ID: 30463516
[TBL] [Abstract][Full Text] [Related]
14. Increased risk of squamous-cell carcinoma in simultaneous pancreas kidney transplant recipients compared with kidney transplant recipients.
Wisgerhof HC; van der Boog PJ; de Fijter JW; Wolterbeek R; Haasnoot GW; Claas FH; Willemze R; Bouwes Bavinck JN
J Invest Dermatol; 2009 Dec; 129(12):2886-94. PubMed ID: 19571820
[TBL] [Abstract][Full Text] [Related]
15. Risk factors and impact of cytomegalovirus disease in simultaneous pancreas-kidney transplantation.
Kaufman DB; Leventhal JR; Gallon LG; Parker MA; Koffron AJ; Fryer JP; Abecassis MM; Stuart FP
Transplantation; 2001 Dec; 72(12):1940-5. PubMed ID: 11773893
[TBL] [Abstract][Full Text] [Related]
16. Cytomegalovirus: occurrence, severity, and effect on graft survival in simultaneous pancreas-kidney transplantation.
Ricart MJ; Malaise J; Moreno A; Crespo M; Fernández-Cruz L;
Nephrol Dial Transplant; 2005 May; 20 Suppl 2():ii25-ii32, ii62. PubMed ID: 15814546
[TBL] [Abstract][Full Text] [Related]
17. Pretransplant prophylactic rituximab to prevent Epstein-Barr virus (EBV) viremia in EBV-seronegative kidney transplant recipients from EBV-seropositive donors: results of a pilot study.
Schachtner T; Reinke P
Transpl Infect Dis; 2016 Dec; 18(6):881-888. PubMed ID: 27632022
[TBL] [Abstract][Full Text] [Related]
18. Different risk factor profiles distinguish early-onset from late-onset BKV-replication.
Schachtner T; Babel N; Reinke P
Transpl Int; 2015 Sep; 28(9):1081-91. PubMed ID: 25959355
[TBL] [Abstract][Full Text] [Related]
19. Incidence and outcomes of cytomegalovirus in pancreas transplantation with steroid-free immunosuppression.
Shah AP; Chen JM; Fridell JA
Clin Transplant; 2015 Dec; 29(12):1221-9. PubMed ID: 26458498
[TBL] [Abstract][Full Text] [Related]
20. EBV, CMV, and BK viral infections in pediatric kidney transplantation: Frequency, risk factors, treatment, and outcomes.
Levi S; Davidovits M; Alfandari H; Dagan A; Borovitz Y; Bilavsky E; Landau D; Haskin O
Pediatr Transplant; 2022 May; 26(3):e14199. PubMed ID: 34817112
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]